Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific, Inc. | 0.25% | 557.20 | 1.0% | $637.39m | |
| DHR | Danaher Corp. | 0.00% | 260.04 | 0.7% | $589.33m | |
| ABT | Abbott Laboratories | -0.03% | 108.70 | 0.8% | $581.63m | |
| MDT | Medtronic Plc | 0.01% | 89.62 | 0.6% | $556.87m | |
| ISRG | Intuitive Surgical, Inc. | 0.47% | 206.31 | 0.8% | $424.36m | |
| BSX | Boston Scientific Corp. | 0.00% | 37.66 | 1.0% | $338.42m | |
| ALGN | Align Technology, Inc. | 0.18% | 250.00 | 6.4% | $291.47m | |
| SYK | Stryker Corp. | -0.12% | 200.51 | 1.3% | $283.36m | |
| BDX | Becton, Dickinson & Co. | 0.01% | 246.28 | 1.0% | $280.25m | |
| EW | Edwards Lifesciences Corp. | 0.04% | 98.03 | 0.4% | $260.37m | |
| IDXX | IDEXX Laboratories, Inc. | 0.14% | 375.74 | 3.8% | $237.22m | |
| DXCM | DexCom, Inc. | 0.36% | 78.63 | 1.9% | $205.00m | |
| BAX | Baxter International, Inc. | -0.71% | 64.61 | 1.8% | $204.44m | |
| A | Agilent Technologies, Inc. | 0.03% | 121.18 | 1.7% | $200.56m | |
| MTD | Mettler-Toledo International, Inc. | 0.00% | 1171.58 | 5.8% | $183.61m |
Company Profile
Exactech, Inc. develops, manufactures, markets, and distributes orthopedic implant devices; and related surgical instrumentation, supplies, and biologic materials to hospitals and physicians in the United States and internationally. It offers knee implant systems that address orthopedic surgeons’ concerns for contact stress, patellar tracking, polyethylene wear, joint stability, bone preservation, and instrumentation; extremities products comprising Equinoxe, a platform shoulder system for the treatment of degenerative disease and trauma; and hip implant systems that address hip arthroplasty, hip fractures, and complex primary hip surgeries. The company also offers biologics and spine products for the healing and regeneration of bone and soft tissues; distributes allograft tissue implants for oral and dental applications; and markets tri-calcium phosphate/hydroxyapatite based synthetic bone graft substitutes. In addition, it offers Ossigen, a 3D matrix of collagen and an organic bone mineral processed into blocks for surgical implantation for the repair of bony defects in the spine, extremities, and pelvis; hip, knee, and shoulder spacers that are used in two stage revision procedures; an air-driven impact handpiece that surgeons could use during joint implant revision procedures to remove failed prostheses and bone cement; and bone cement systems. The company markets its orthopedic implant products through a network